Pfizer’s Omicron-Targeting Covid-19 Vaccines Generate Stronger Immune Response – The Wall Street Journal
Pfizer Inc. and BioNTech SE vaccines modified to target the Omicron variant produced a significantly larger immune response than the companies currently available vaccine in a study, they said.
A mo… [read more]
/cloudfront-us-east-2.images.arcpublishing.com/reuters/WPIWBLHQKJC25ICXYYLLRGKH7Y.JPG "Russian column stalled for days outside Kyiv – Reuters")
